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Membranous webDuring replication, hepatitis C virus (HCV) NS4B protein rearranges intracellular membranes to form foci, or
the web, the putative site for HCV replication. To understand the role of the C-terminal domain (CTD) in
NS4B function, mutations were introduced into NS4B alone or in the context of HCV polyprotein. First, we
show that the CTD is required for NS4B-induced web structure, but it is not sufﬁcient to form the web nor is
it required for NS4B membrane association. Interestingly, all the mutations introduced into the CTD impeded
HCV genome replication, but only two resulted in a disruption of NS4B foci. Further, we found that NS4B
interacts with NS3 and NS5A, and that mutations causing NS4B mislocalization have a similar effect on these
proteins. Finally, we show that the redistribution of Rab5 to NS4B foci requires an intact CTD, suggesting that
Rab5 facilitates NS4B foci formation through interaction with the CTD.
© 2009 Elsevier Inc. All rights reserved.Introduction
Hepatitis C virus (HCV) is a positive strand RNA virus that belongs
to the Flaviviridae (Kato et al., 1990; Miller and Purcell, 1990) family
of viruses including ﬂaviviruses like Dengue virus andWest Nile virus,
as well as pestiviruses such as bovine viral diarrhea virus (BVDV). HCV
belongs to a separate genus known as hepacivirus. Many positive
strand RNA viruses replicate their genome in association with intra-
cellular membranes. In some cases, these viruses rearrange internal
membranes to form novel structures that provide the platform for all
the components of the virus replication machinery. For HCV, these
membrane structures, termed the membranous web, or web (Egger
et al., 2002), have been observed in virus-infected cells (Rouille et al.,
2006), cells expressing the subgenomic replicon (Gosert et al., 2003),
precursor NS4A-B (Konan et al., 2003), or mature NS4B protein (Egger
et al., 2002; Konan et al., 2003). The web contains the HCV replication
complex (RC), which includes the replicase proteins (NS3, NS4A,
NS4B, NS5A and NS5B), viral RNA and host factors. The web is thought
to concentrate the replication machinery in speciﬁc subcellular
locations to optimize HCV RNA synthesis, prevent double stranded
RNA-activated interferon response in infected cells, protect viral RNA
from host nucleases and proteases, or perhaps hinder host acquiredll rights reserved.immune response to HCV infection by reducing MHC-I cell surface
presentation (Konan et al., 2003).
HCV NS4B is a poorly characterized hydrophobic protein, approx-
imately 27-kDa in size (Hugle et al., 2001). The only biochemical
functions associated with NS4B are its GTPase and ATPase activities
(Einav et al., 2004; Thompson et al., 2009), but there is no evidence
that these activities are associated with the formation of NS4B foci,
which contain the HCV RC. Recently, it has been suggested that NS4B
GTPase activity might play a role in NS4B-induced cellular transfor-
mation and tumor formation (Einav et al., 2008b). Further, NS4B has
been reported to bind to the 3′ end of negative strand viral RNA (Einav
et al., 2008a), suggesting that NS4B might tether HCV RNA onto the
membranous web and facilitate positive sense RNA synthesis. Other
activities associated with NS4B expression include modulation of
NS5A hyperphosphorylation (Jones et al., 2009; Koch and Bartens-
chlager, 1999), transactivation of interleukin 8 promoter (Kadoya
et al., 2005), suppression of translation (Kato et al., 2002) and
modulation of the ER stress response through interaction with
activating transcription factor 6β (Tong et al., 2002; Zheng et al.,
2005). When co-expressed in separate constructs, NS4B protein has
been found to interact with other nonstructural (NS) proteins (NS3,
NS4A, NS5A and NS5B), all of which are involved in HCV RNA
synthesis (Ali et al., 2002; Alter, 1997; Egger et al., 2002; El-Hage and
Luo, 2003; Gosert et al., 2003; Ishido et al., 1998). These ﬁndings
suggest that NS4B might provide the scaffold for the formation of the
HCV RC. Similarly, BVDV NS4B has been shown to bind to NS3 and
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2001). Altogether, these reports indicate that NS4B plays a central role
in genome replication among the Flaviviridae family of viruses. Finally,
we have recently reported that NS4B interacts with Rab5, an early
endosome protein with a putative role in the formation of the HCV RC
(Stone et al., 2007).
The precise membrane topology of NS4B remains controversial; it
is predicted to have at least four transmembrane domains (TMDs)
(Lundin et al., 2003) with the last 70 amino acids (residues 192 to
261), also called the NS4B C-terminal domain (NS4B CTD), on the
cytosolic side of the endoplasmic reticulum (ER) membrane. Until
recently, very little was known about the role of NS4B CTD in NS4B
function. Some of the features associated with the CTD include genetic
interaction with NS3 protein (Paredes and Blight, 2008), involvement
in NS4B oligomerization (Yu et al., 2006), interaction with viral RNA
(Einav et al., 2008a), and hyperphosphorylation of NS5A protein
(Jones et al., 2009). A recent report has also shown that the NS4B CTD
is partially responsible for NS4B association with host membranes
(Liefhebber et al., 2009). By comparison, the N-terminal domain has
been reported to have NS4B GTPase activity (Einav et al., 2004;
Thompson et al., 2009) and contains two alpha helices involved in
NS4B host membranes association (Elazar et al., 2004; Gouttenoire et
al., 2009).
To further elucidate the role of the NS4B protein in HCV
replication, we have focused on the CTD. Since the CTD is cytosolic,
we hypothesized that this domain plays an important role in HCV
genome replication, perhaps through interaction with viral and
host factors. In this report, we have used genetic and biochemical
approaches to examine the CTD. We show that most of the tested
residues in NS4B CTD are required for HCV genome replication.
However, very few of the residues examined contribute to the
formation of NS4B foci, which may represent HCV replication
complexes. The signiﬁcance of these ﬁndings will be discussed.
Results
Deletion of the NS4B CTD correlates with a disruption of the web
NS4B protein induces the web (Egger et al., 2002; Konan et al.,
2003), which has been postulated to be the site for HCV
replication. The web often appears as foci in cells expressing
NS4B alone or in the context of the HCV replicon (Elazar et al.,
2004; Lundin et al., 2003; Stone et al., 2007). To identify the
determinants of NS4B-induced web formation, we focused ﬁrst on
the NS4B CTD, which has been predicted to be on the cytosolic
side of the ER membrane (Lundin et al., 2006), is highly conserved
among HCV isolates (Fig. 1A), and likely to be engaged in
protein–protein interactions required for NS4B function. To deﬁne
the role of the CTD in the formation of the web, Wt and
truncated NS4B derivatives were engineered, each with a C-
terminal GFP fusion to NS4B (Fig. 1B). GFP was chosen because it
was shown previously not to alter NS4B membrane association or
function (Elazar et al., 2004; Lundin et al., 2003). The resulting
constructs were transfected into Huh7.5 cells and at 48 h post-
transfection, the lysates were examined for NS4B expression using
GFP antibody. As shown in Fig. 1C, Wt and mutant NS4B proteins
were expressed similarly, suggesting that the deletions did not
have a signiﬁcant effect on NS4B expression or stability. Interest-
ingly, a band similar in size to that of GFP protein could be
observed in most of the NS4B-GFP fusion constructs, suggesting
perhaps a partial internal translation initiation or degradation of
NS4B protein.
We ﬁrst tested the effects of NS4B CTD truncations on Wt NS4B
subcellular distribution via ﬂuorescence microscopy. GFP-fused
constructs were detected both by GFP ﬂuorescence and GFP
staining. As shown in Fig. 1D (i–iii), expression of GFP aloneresulted in a diffuse subcellular distribution with some nuclear
ﬂuorescence, whereas Wt NS4B-GFP showed the foci and peri-
nuclear distribution (Fig. 1D, iv–vi) typically associated with native
NS4B protein (Elazar et al., 2004; Hugle et al., 2001; Lundin et al.,
2003). Interestingly, NS4B CTD truncations fell into three groups:
one group displayed NS4B foci [(Δ192–226; Fig. 1D, vii–ix) and
(Δ227–261; Fig. 1D, xvi–xviii) which were smaller and more
numerous than the Wt. The second group showed an intermediate
phenotype (Δ227–250; Fig. 1D, xiii–xv) consisting of a mostly
reticular distribution with few scattered smaller foci. Finally, the
last group (Δ192–261; Fig. 1D, x–xii) exhibited a reticular NS4B
distribution, which was different from GFP expressed alone. These
results suggest that the NS4B CTD is required for Wt NS4B
subcellular distribution.
To elucidate the role of the CTD in the formation of the web,
Huh7.5 cells expressing GFP, GFP-fused Wt NS4B (NS4B-GFP), or
CTD-truncated NS4B [NS4B Δ (192–261)-GFP] protein, were
examined via transmission electron microscopy (TEM). If NS4B
CTD is required for the formation of the web, we hypothesized that
a deletion of this CTD would lead to a disruption of this membrane
structure. To ensure that we could reproducibly observe the web
under transient conditions, transfected cells were sorted to enrich
the GFP- or NS4B-GFP-expressing cell population, followed by
immunoblotting to conﬁrm NS4B expression (data not shown).
Since sorting results indicated that 70–90% of the transfected cells
were positive for GFP expression, these cells were processed for
subsequent TEM analysis. As shown in Fig. 2Aii, cells expressing
NS4B-GFP typically contained a cluster of vesicles characteristic of
the web. This rearranged membrane was found in approximately
40% of the NS4B-GFP-expressing cells by 48 h post-transfection.
Cells expressing GFP alone did not show such a vesicle cluster (Fig.
2Ai), suggesting that the web was speciﬁcally induced by NS4B-
GFP expression. Interestingly, when the cells were transfected with
NS4B Δ(192–261)-GFP construct, the vesicles were formed but
were no longer clustered. Instead, these vesicles were scattered
throughout the cytosol (Fig. 2A iii and iv), suggesting that NS4B
CTD might be required for the formation of the web. However, these
results could not be explained by a change in NS4B membrane
association. Indeed, when subjected to membrane ﬂoatation assay
(Elazar et al., 2004), the membrane association of Wt NS4B and its
CTD truncation counterpart was similar to calnexin (Fig. 2B), an
integral membrane protein. The proﬁle for these proteins was
different from GFP and GAPDH, both soluble proteins (Fig. 2B). Like
Wt NS4B, these data indicate that NS4B Δ(192–261)-GFP gene
product was still membrane-bound.
Expression of the NS4B CTD alone is not sufﬁcient for web formation
The ﬁnding that the CTD truncations alter Wt NS4B subcellular
distribution led us to determine whether the CTD alone could form
NS4B foci as well as the web. As shown in Fig. 3A (i and ii),
expression of the GFP-fused CTD [(192–261)-GFP or GFP-(192–
261)] resulted in few foci with hollow foci resembling rings.
Further, the location of GFP with respect to the CTD did not seem
to have a major impact on NS4B ﬂuorescence. These results imply
that the CTD may not be sufﬁcient to form the Wt NS4B foci.
Interestingly, cells expressing the CTD alone did not appear to
induce the cluster of vesicles typically observed with Wt NS4B
protein. As shown in Fig. 3B (ii), Huh7.5 cells with GFP-fused CTD
[(192–261)-GFP] protein displayed vesicles that were at least 1 μm
in diameter, whereas the web-associated vesicles were usually less
than 200 nm (compare 3Bii to 3Bi). More importantly, when NS4B
(192–261)-GFP was expressed for 48 h, it was found to be
cytotoxic and the intracellular vesicles were as large as 2 μm in
diameter (data not shown). Taken together, these data suggest that
the CTD alone may not be sufﬁcient to induce the web structure.
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Since NS4B CTD is required for the formation of the web, we
predicted that some missense mutations in this domain would
impede HCV genome replication. To test this hypothesis, we used
PSIPRED (http://www.predictprotein.org/meta.php), a protein sec-
ondary structure prediction program, to search for putative structures
in NS4B CTD. As shown in Fig. 4B, two α helices referred to as helix 1
and helix 2 were identiﬁed in the CTD. We focused our investigation
on helix 2 because its deletion resulted in an intermediate NS4B
subcellular distribution [compare Fig. 1D (iv–vi to xiii–xv)], implying
that it could be involved in some aspect of NS4B function. Themutated
CTD residues were targeted for two reasons. First, we chose conservedFig. 1. A. The amino acid sequence of NS4B CTD from various HCV isolates. Highly conse
representation of Wt and NS4B truncation constructs. The predicted transmembrane dom
represent the N-terminus amphipathic alpha helix and the CTD. Note that all these const
truncations on its subcellular distribution when expressed alone. (++) Means foci resembl
Means intermediate phenotype with mostly a reticular distribution and few foci, whereas (
NS4BGFP or various NS4B deletion constructs. At 48 h post-transfection, 60 μg of cell lysat
antibody. Lane 1: control GFP vector; lane 2: N4B-GFP; lane 3: Δ(192–261)-GFP; lane 4: Δ(22
expected bands for GFP and NS4B fusion proteins. Notice that most of the constructs expre
constructs. Wt and various NS4B CTD truncations were transfected into Huh7.5 cells. At 48 h
displays the characteristic NS4B foci (iv–vi), whereas truncations result in numerous and sm
visible foci (x–xii). Bars=10 μm.residues on the basis that they are essential for NS4B function(s)
among all the HCV genotypes. Secondly, roughly every third amino
acid (between positions 227 and 250) was subjected to a non-
conservative substitution because we postulated that such mutations
could reveal whether the mutated residues have functions other than
their role in the formation of the web. The following substitutions
were engineered (D228A, V233R, L237E, S239W, T241A, L245D and
H250E) (Figs. 1A and 4B) and the mutated gene was subcloned into
the subgenomic replicon with a C-terminal GFP fusion to NS5A (Fig.
4A) (Moradpour et al., 2004).
To determine the effect of NS4B CTDmutations on HCV replication,
in vitro transcribed RNA was generated fromWt and mutant replicon
DNA constructs and electroporated into Huh7.5 cells. At 24 h post-rved residues are highlighted, whereas stars indicate mutated residues. B. Schematic
ains (TMD1 to TMD4) (Lundin et al., 2003) are shown as dark boxes. Hatched boxes
ructs have a C-terminal GFP fusion. Also shown are summaries of the effect of NS4B
ing Wt NS4B distribution. (+) Refers to NS4B with smaller and numerous foci. (+/−)
−) signiﬁes reticular NS4B distribution. C. Huh7.5 cells were transfected with GFP, WT
es were separated on 10% SDS-PAGE and subjected to immunoblotting using anti GFP
7–261)-GFP; lane 5: Δ(227–250)-GFP; lane 6: Δ(1–191)-GFP. Arrowheads indicate the
ssed similar levels of NS4B protein. D. Subcellular distribution of Wt and mutant NS4B
post-transfection, the cells were processed for ﬂuorescence microscopy. Wt NS4B-GFP
aller foci (vii–ix and xvi–xviii), mostly reticular distribution and few foci (xiii–xv) or no
Fig. 1 (continued).
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Fig. 2. A. Ultrastructural analysis of cells expressing Wt or truncated NS4B protein. Huh7.5 cells were transfected with GFP, NS4B-GFP or a CTD truncation [Δ (192–261)-GFP]
construct. At 48 h post-transfection, the cells were processed for TEM analysis. The circled area shows the cluster of vesicles characteristic of the web (ii). Cells expressing NS4B
Δ(192–261)-GFP show vesicles scattered in the cytosol (compare iii and iv to ii). No cluster of vesicles was found in control GFP-expressing cells (i). Bars=1 μm. B. Membrane
distribution ofWt and NS4B Δ(192–261)-GFP fusion proteins. Cells were transfected with constructs as described above. Three hundredmicrograms of cell extract were subjected to
membrane ﬂoatation, followed by western blot with GFP-, calnexin- or GAPDH-speciﬁc antibody. Lysate refers to crude lysate. Lanes 1 to 4: membrane fractions and lanes 5 to 8:
soluble fractions.
72 J. Aligo et al. / Virology 393 (2009) 68–83electroporation, complete DMEM with 0.5 mg/ml G418 was added to
the cells to select for neomycin-resistant clones. The replication
potential of Wt and mutant replicon RNAs was measured in colonyformation units per microgram of input RNA (CFU/μg RNA). As shown
in Fig. 4C, the replicon construct expressing Wt NS4B protein
replicated efﬁciently. As expected, no G418-resistant clones were
Fig. 3. A. Subcellular distribution of GFP-fused NS4B CTD constructs. NS4B CTD constructs [(192–261)-GFP or GFP-(192–261)] were transfected into Huh7.5 cells. At 24 h post-
transfection, the cells were processed for ﬂuorescence microscopy. Notice that there are few foci and numerous hollow foci. Bars=10 μm. B. Ultrastructural analysis of cells
expressing NS4B-GFP (i) and NS4B (192–261)-GFP (ii) proteins. Cells were transfected as above and processed for TEM analysis. Square areas show vesicular structures. Higher
magniﬁcation of the square areas is indicated by the arrows. Notice the presence of larger vesicles in (ii), in comparison to (i). Bars=1 μm.
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vector. Interestingly, all the replicon constructs with NS4B CTD
mutations showed a dramatic decrease (at least 28-fold) in HCV
genome replication. The replicons containing NS4B D228A, T241A and
L245D mutations resulted in few G418-resistant clones whereas the
least viable mutations were V233R, L237E and S239W. These data
suggest that the conserved amino acid sequence of helix 2 of the CTD
is indispensable for HCV genome replication.
NS4B CTD mutations do not affect NS4B synthesis or HCV polyprotein
processing
Several plausible scenarios could explain why the mutations in
NS4B CTD impede HCV genome replication. First, these mutations
could affect NS4B synthesis, stability or polyprotein processing.Alternatively, they could affect NS4B interaction with viral or host
factors involved in the formation of the HCV RC.
To test whether the CTD mutations alter NS4B synthesis or
stability, Huh7.5 cells were transfected with DNA constructs expres-
sing HCV polyprotein containing Wt or mutant NS4B. First, we
determined the transient transfection and (35S)-methionine labeling
conditions under which, expression of the Wt polyprotein could lead
to detectable levels of both the mature replicase proteins and their
precursor forms. As shown in Fig. 5A, when transiently expressed in
Huh7.5 cells, most of the replicase proteins and their precursors
(NS4A-B, NS4B-5A and NS5A-5B) were detected as early as 10 min
after pulse labeling followed by immunoprecipitation (IP) with
replicase-speciﬁc antibodies. Notably, when NS4B antibody was
used, mature NS4B protein as well as its precursors (NS4A-B and
NS4B-5A) could be detected. Additionally, a substantial amount of
Fig. 4. Effect of NS4B CTD mutations on HCV genome replication. A. Schematic representation of the NS5AGFP subgenomic replicon construct (Moradpour et al., 2004) used in this
study. B. Sequence of NS4B CTD from Con1. Shown are alpha helical structures 1 and 2 predicted by PSIPRED program. The stars indicate the mutated residues in helix 2 and the
substitutions are shown underneath. C. Five micrograms of RNA transcripts, from Wt and NS4B CTD mutant replicons, were electroporated into Huh7.5 cells. After three weeks of
selection, G418-resistant colonies were ﬁxed and stained with crystal violet. Numbers below each dish indicate the colony forming units/μg (CFU/μg) of input in vitro replicon
transcript. Notice that most of the NS4B CTD mutations resulted in a major decrease in the number of G418-resistant clones. Results represent values from at least two independent
electroporations.
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also be seen. Further, when NS3 antibody was used, NS3 protein was
detected as well as was a small amount of NS4A-B. These results
suggest biochemical interactions between NS4B and at least NS3
protein in the context of the HCV replicase proteins. A band whose
molecular weight is slightly higher than NS4B protein (shown by
asterisks) was observed in αNS3, αNS4B and αNS5A lanes. The
identity of this protein is not clear although it could represent a
posttranslational modiﬁcation of NS4B. Finally, when pooled NS3-,
NS4B-, NS5A- and NS5B-speciﬁc antibodies were added to the cellFig. 5. Effect of NS4B CTD mutations on polyprotein processing. A. Huh7.5 cells were co-
expression vector. At 48 h post-transfection, the cells were labeled with (35S)-methionine fo
NS3, NS4B, NS5A or NS5B protein. Alternatively, the labeled cells were chased for 60 min and
IP'd proteins were separated on 10% SDS-PAGE and visualized by autoradiography using a p
asterisks in the αNS4B lane). Also notice the slowly migrating band (above NS4B) indicated
polyproteins. Huh7.5 cells were co-transfected with DNA constructs as described above. At
speciﬁc antibodies, SDS-PAGE and visualization as described above. Notice that the levels of t
NS4B-5A and NS5A-B appear to be processed by 60 min chase. C and D. Effect of NS4B CTD
above. At 48 h post-transfection, the cells were labeled with (35S)-methionine for 15 min,
antibody and processed as described above.lysates, most of the precursors were processed following a 60 min
chase. On the basis of these results, a similar pulse-chase experiment
was performed on cells expressing Wt or mutant polyprotein
followed by IP with HCV-speciﬁc antibodies. As shown in Fig. 5B, no
aberrant processing products were observed in cells transiently
expressing the mutant polyproteins. The expression levels of most
of the replicase proteins were comparable. Taken together, these
results imply that mutations in the CTD may not signiﬁcantly affect
NS4B translation rate, stability or polyprotein processing. We also
found that NS4B stability was not altered when cells expressing Wttransfected with WT DNA construct expressing HCV polyprotein and T7 polymerase
r 10 min and the lysates were immunoprecipitated (IP'd) with HCV-speciﬁc antibody to
the lysates were IP'd with pooled HCV-speciﬁc antibodies to NS3, NS4B, NS5A or NS5B.
hosphorImager. Notice that IP of NS4B protein results in the coIP of NS3 (indicated by
by asterisks in the αNS3, αNS4B and αNS5A lanes. B. Processing of Wt and mutant HCV
48 h post-transfection, the cells were pulse-labeled, followed by IP with pooled HCV-
he mature proteins are similar betweenWt andmutant polyproteins. Precursor NS4A-B,
mutations on NS4B synthesis and stability. Huh7.5 cells were transfected as described
followed by a 30 min and 120 min chase. The cell lysates were IP'd with NS4B-speciﬁc
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Fig. 6. Effect of the CTD missense mutations on NS4B subcellular distribution. Wt and mutant NS4B-GFP constructs were transfected into Huh7.5 cells. At 48 h post-transfection, the
cells were processed for ﬂuorescence microscopy. Note that Wt NS4B-GFP as well as most of the mutant [D228A (ii), S239W (v), T241A (vi), L245D (vii), and H250E (viii)] proteins
show the characteristic punctate foci and perinuclear distribution. Interestingly, V233R (iii) displays perinuclear, but elongated foci, whereas L237E (iv) exhibits a reticular
distribution. Bars=10 μm.
76 J. Aligo et al. / Virology 393 (2009) 68–83and mutant constructs were subjected to a 2 h chase (Fig. 5C)
followed by IP with NS4B-speciﬁc antibody. However, since NS4B
half-life is approximately 11 h (Pietschmann et al., 2001), we cannot
rule out the possibility that translation rate and polyprotein proces-
sing were not signiﬁcantly altered for the CTD mutations.
Mutations in NS4B V233 and L237 alter the subcellular distribution of
NS5A and NS3 proteins
To elucidate themechanismwhereby NS4B CTDmutations impede
HCV genome replication, we examined the effect of these mutations
on NS4B subcellular distribution. First, Wt or mutant NS4B was tested
alone with a C-terminal GFP fusion. When these proteins were
transiently expressed in Huh7.5 cells, their subcellular distribution fell
into three distinct groups. One group (D228A, S239W, T241A, L245D
and H250E) consistently showed a subcellular distribution similar to
the Wt NS4B construct (Fig. 6i, ii and v–viii). The second group
(V233R) had an intermediate phenotype (elongated foci), whereas
the last group (L237E) displayed a mostly reticular NS4B distribution
with few foci (Fig. 6iii and 6iv, respectively). Taken together, these
ﬁndings suggest that two NS4B CTD mutations (V233R and L237E)
may result in the mislocalization of NS4B in the cell.
To test the effect of NS4B substitutions (V233R and L237E) on
other replicase proteins, these mutations were examined in thecontext of the HCV polyprotein. Brieﬂy, Huh7.5 were transiently
transfected with DNA constructs expressing HCV polyprotein contain-
ing Wt or mutant NS4B. At 48 h post-transfection, the cells were
stained with NS4B-speciﬁc antibody whereas N5A was detected with
the C-terminally fused GFP. As shown in Fig. 7A (i–iii), NS4B foci were
observed and these foci merged with NS5AGFP ﬂuorescence in the
context of the Wt polyprotein. However, when the V233R mutation
was expressed in the polyprotein, NS4B displayed a more reticular
pattern (Fig. 7Aiv). More importantly, this change in NS4B staining
resulted in a similar alteration in NS5A subcellular distribution
(compare Fig. 7Av to Aii). Like V233R, when L237E was expressed
in the polyprotein, both NS4B and NS5A displayed a reticular
distribution (compare Fig. 7Avii and Aviii). These data indicate that
the two NS4B CTD mutations (V233R and L237E) caused a similar
change in the intracellular distribution of both NS4B and NS5A
proteins. Finally, we also tested whether such NS4B mutations had
any effect on the distribution pattern of NS3, another replicase
protein. As shown in Fig. 7B (iv–ix) and the table below, a change in
Wt NS5A intracellular distribution resulted in a concomitant change
in NS3 subcellular pattern (NS5A ﬂuorescence is used here because
NS5A co-localizes with NS4B in the context of the polyprotein). Taken
together, these data indicate that NS4B, NS3 and NS5A are
mislocalized in cells expressing NS4B V233R and L237E mutant
proteins.
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Rab5 protein
We have reported previously that Rab5 (an early endosome
protein) is associated with HCV replicase proteins, and that silencing
of Rab5 results in a signiﬁcant decrease in NS5A foci as well as HCV
replication (Stone et al., 2007). Since Rab5 is associated with NS4B
foci, we hypothesized that any alteration in NS4B subcellular
distribution would result in a similar change in Rab5. Indeed, in
cells expressing theWt polyprotein, Rab5 displays approximately 47%
co-localization with NS5A protein [Fig. 8 (A, i–iii and table)] and those
Rab5 foci appear to be as large as NS5A foci. However, when mutant
polyproteins (with NS4B V233R or L237E) were expressed, Rab5
showed little to no co-localization with NS5A protein [Fig. 8 (A, iv–ix
and table)]. Rab5 was also not redistributed in these cells and the foci
were similar in size to Rab5 in parental cells (compare Fig. 8A, iv–ix toFig. 7. Effect of the NS4B CTD mutations on the subcellular localization of NS5A and NS3. A
polyprotein as described above. At 48 h post-transfection, the cells were processed for ﬂuores
in cells with Wt polyprotein, NS4B and NS5A foci merge (i to iii). A mutation of valine to ar
distribution of both NS4B and NS5A proteins. B. Huh7.5 cells were co-transfected with Wt
antibody. Notice that NS3 and NS5A foci merge in the Wt construct (i to iii). In the mutant
Percent co-localization between NS3 and NS5A was calculated using Axiovision software (vxiii). These results suggest that NS4B residues V233 and L237 may be
involved in the recruitment of Rab5 to NS4B foci. Finally, mutations
that had no visible effect on Wt NS4B subcellular pattern (e.g. NS4B
S239W; Fig. 8A, x–xii) also redistributed Rab5 cellular localization.
These data are consistent with the ﬁndings that HCV NS4B-induced
foci are associated with cellular Rab5 protein (Stone et al., 2007).
Discussion
Expression of HCV NS4B protein results in the formation of the
web, which contains the HCV replication complex. Yet, very little is
known about NS4B determinants of web induction. In this study, we
show ﬁrst that the NS4B CTD is required for the formation of NS4B foci
and the web. However, we found that the CTD alone may not be
sufﬁcient to induce these structures. These results are consistent with
previous report indicating that the NS4B N-terminal domain (NTD). Huh7.5 cells were co-transfected with Wt or mutant DNA constructs expressing HCV
cence (NS5AGFP) or immunoﬂuorescence (IF) with NS4B-speciﬁc antibody. Notice that
ginine (V233R; iv to vi) or leucine to glutamate (L237E; vii to ix) results in a reticular
or mutant constructs as described above except that IF was performed using anti NS3
constructs (iv to ix), both NS5A and NS3 display a reticular distribution. Bars=10 μm.
. 4.5, Carl Zeiss). The data represent co-localization from ﬁve NS5A-expressing cells.
Fig. 7 (continued).
78 J. Aligo et al. / Virology 393 (2009) 68–83also plays a role in the formation of NS4B foci (Elazar et al., 2004).
Secondly, helix 2 in the CTD has multiple functions. Indeed, although
all the seven mutations introduced into this helix impede HCV RNA
synthesis (summary results in Table 1), only two of them (V233R and
L237E) result in a disruption of NS4B foci. These data suggest that
formation of NS4B foci may not be sufﬁcient for HCV genome
replication. Third, we show that NS4B interacts weakly with NS5A and
strongly with NS3 in the context of the other replicase proteins, and
that the two mutations leading to a disruption of NS4B foci have a
similar effect on NS3 and NS5A. Finally, our data imply that NS4B CTDFig. 8. Effect of the NS4B CTDmutations on the subcellular pattern of Rab5B protein. Huh7.5 c
was performed using anti Rab5B antibody. Notice that some Rab5B and NS5A foci merge in ce
merge with NS5A appear to be much larger than those with no NS5A overlap. In cells ex
distribution, which shows little overlap with Rab5B foci. Bars=10 μm. Mock-transfected ce
calculated using Axiovision software (v. 4.5, Carl Zeiss). The data represent co-localizationresidues, V233 and L237, play a role in early endosome protein Rab5
association with NS4B foci.
We chose to investigate the NS4B CTD contribution to NS4B
function for several reasons. First, NS4B membrane topology predicts
that the CTD is on the cytosolic side of the ER membrane (Elazar et al.,
2004; Lundin et al., 2003; Qu et al., 2001) and is possibly engaged in
interactions required for HCV replication (Einav et al., 2008a). Second,
in comparison to the NTD, the CTD has considerable sequence identity
(ca. 85% amino acid sequence similarity) among all the different HCV
isolates (Fig. 1A), suggesting that it might play a major role in NS4Bells were co-transfected withWt or mutant constructs as described above except that IF
lls expressingWt (i to iii) or mutant S239W (x to xii) polyprotein. Those Rab5B foci that
pressing mutant NS4B V233R and L237E proteins (iv to ix), NS5A displays a reticular
lls show typical Rab5B foci (xiii). Percent co-localization between NS5A and rab5B was
from at least ﬁve NS5A-expressing cells.
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Table 1
Summary of NS4B mutations.
Wt Mutation NS4B Polyprotein NS4B
distribution
Subgenomic
replicon NS4B
distribution
Replication
(gac) (gct) D228A D1939A + + +/−
(gtc) (cgt) V233R V1944R +/− − −
(ctc) (gag) L237E L1948E − − −
(agt) (tgg) S239W S1950W + + −
(acc) (gca) T241A T1952A + + +/−
(ctg) (gac) L245D L1956D + − +/−
(cac) (gag) H250E H1961E + + −
(+): Indicates Wt phenotype for NS4B subcellular distribution (foci) or HCV genome
replication (ca. 4×103 CFU/g input RNA).
(+/−): Indicates intermediate phenotype for NS4B subcellular distribution (elongated
foci) or attenuated HCV replication (less than 200 CFU/g input RNA).
(−): Signiﬁes reticular NS4B distribution or no detectable G418-resistant clones.
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contain two alpha helical structures termed helix 1 and helix 2 (Fig.
4B). For the NTD, speciﬁcmutations in the two helices have resulted in
the loss of NS4B foci (Elazar et al., 2004; Gouttenoire et al., 2009).
Likewise, we have found that mutations in the CTD can lead to some
alteration in Wt NS4B subcellular distribution. However, for the CTD,
the most severe alterations were observed following truncation of the
entire CTD, deletion of most of helix 2 residues, or V233R and L237E
substitution mutations. These ﬁndings suggest that both the NTD and
helix 2 in the CTD are needed for the formation of NS4B foci.
Since NS4B CTD is required but not sufﬁcient for the formation ofWt
NS4B foci, we reasoned that the CTD alone could not facilitate web
formation. Indeed, when observed under TEM, the presence of
unusually large vesicles (at least 1 μm in diameter) in cells expressing
the CTD implies that this domain alone may interfere with web-like
vesicles formation or may cause more of such vesicles to fuse. In
contrast, the cytoxicity associated with the CTD expression could be
interpreted tomean that this domain alonemight interferewith normal
vesicular trafﬁcking. Note that the CTD construct used in this study, and
others (Elazar et al., 2004; Targett-Adams et al., 2008), contains NS4B
residues 192 through 261. Recently, another CTD construct was found
to displaymostly small NS4B foci in Huh7 cells (Liefhebber et al., 2009).
However, this subcellular distribution could be explained in part by the
fact that the CTD included residues 188 through 261, and therefore four
additional residues from transmembrane domain 4.
We have identiﬁed V233 and L237 as two putative CTD
determinants required for the formation of NS4B foci since mutations
in these residues result in a signiﬁcant disruption of Wt-like NS4B foci
and a similar mislocalization of the replicase proteins NS3 and NS5A.
One plausible scenario is that V233 and L237may participate in NS4B-
NS4B (Yu et al., 2006) or NS4B-host protein interactions involved in
the formation of these foci. Conversely, it is possible that the non-
conservative mutations introduced into these residues (V233R and
L237E) resulted in some structural modiﬁcation in the CTD that could
be deleterious for NS4B function. Indeed, a helical wheel prediction
program, http://cti.itc.Virginia.EDU/~cmg/Demo/wheel/wheelApp.
html, suggests that helix 2 might be an amphipathic alpha helical
structure. Studies are under way to test this prediction.
The ﬁndings that NS4B may interact with NS3 in the context of
other replicase proteins are supported by a report from Paredes and
Blight (2008) indicating a genetic interaction between NS4B and NS3
protein. Our study suggests that the mutated CTD helix 2 residues
may not be required for this interaction (data not shown), but we
cannot completely rule out interaction with the other residues in
helix 2 or the remainder of the CTD. In contrast, the current report
suggests that some CTD mutations may have altered NS4B interaction
with host factor(s). Speciﬁcally, we have previously shown that NS4B
interacts with Rab5, an early endosome protein (Stone et al., 2007),
and that Rab5 silencing results in a loss of NS4B foci and a signiﬁcantdecrease in HCV RNA synthesis (Stone et al., 2007). Additionally, a
recent report shows that Rab5 is required for cell culture JFH1
genome replication (Berger et al., 2009) further conﬁrming the
importance of Rab5 in HCV replication. Here, we demonstrate that
Rab5 co-localizes with Wt and mutant NS4B proteins that display
punctate ﬂuorescence. However, the two CTD mutations (V233R and
L237E) that resulted in the loss of NS4B foci no longer displayed NS4B
co-localization with Rab5. Studies are under way to examine possible
alterations in the interaction between the various NS4B mutant
proteins and Rab5 co-factor.
In summary, we have identiﬁed the CTD as a determinant in NS4B
ability to form the membranous web, a site of HCV genome
replication. The cytoplasmic location of the NS4B CTD suggests
plausible interactions with viral and host factors required for NS4B
function in the context of HCV replication.
Materials and methods
Cells
Cells expressing the NS5AGFP replicon (Moradpour et al., 2004)
were derived from Huh7.5 cells, a highly permissive cell line for HCV
replication (Blight et al., 2002), and were obtained from Dr. Charles
Rice (The Rockefeller University, New York, NY). Replicon and
parental cells were grown as monolayers in Dulbecco's Modiﬁed
Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), non-essential amino acids (NEAA, Invitrogen), 100 U/ml
penicillin, and 100 μg/ml streptomycin at 37 °C in a 5% CO2 incubator.
Replicon cells were also cultured in the presence of 0.3–0.5 mg/ml
G418 (Geneticin, Invitrogen, Carlsbad, CA).
Plasmids
To construct plasmids carrying NS4B (WT and deletion mutations)
with a C-terminal GFP fusion, NS4B was ampliﬁed from genotype 1B,
strain Con 1 or J4L6S (Lohmann et al., 1999; Yanagi et al., 1998).
Speciﬁcally, truncations were introduced into J4L6S NS4B sequence,
whereasmissensemutationswere engineered intoCon1NS4B sequence.
Primers (Table 2) were designed to introduce a SalI site at the 5′end, a
BamHI site at the 3′ end, and an AUG start codon immediately upstream
of the NS4B coding region. The PCR products were digestedwith SalI and
BamHI, and the puriﬁed fragmentswere subcloned into SalI- and BamHI-
cleaved pEGFP-N2 vector (Clontech, Mountain View, CA).
For site-directed mutagenesis, the QuikChange PCR method
(Stratagene, La Jolla, CA) was used. Brieﬂy, two PCR primers, one
with NS4B mutation and another with the Wt sequence, were used to
amplify recombinant pCR 2.1-TOPO vector (Invitrogen, Carlsbad, CA)
containing a 1.2 kb fragment (including NS4A-NS4B-NS5A sequence)
ﬂanked by NsiI at the 5′end and MluI at the 3′ end. To subclone NS4B
mutations into pEGFP-N2 vector, NS4B was ampliﬁed using two PCR
primers, one ﬂanked by SalI and the other by BamHI. The PCR product
was digested with SalI (5′ end) and BamHI (3′ end) and cloned into
SalI- and BamHI-cleaved pEGFP-N2 to generate the recombinant
vector expressing Wt or mutant NS4B alone.
The NS4B mutant replicon constructs were engineered in two
steps. First, pI/5A-GFP-6 (generously provided by Charles Rice, The
Rockefeller University) (Moradpour et al., 2004) was digested with
SspI (5′ end) and MluI (3′ end) to remove an 868 bp fragment
containing NS4B ﬂanked by part of NS4A and NS5A sequences. Then, a
1.6 kb fragment [containing EMCV IRES and some pEGFP-N2 vector
(Clontech) sequence] was digested with SspI and MluI, followed by
ligation into SspI- and MluI-cleaved pI/5A-GFP-6 to create an
intermediate vector. Finally, Wt or mutant NS4B DNA fragment (in
pCR 2.1-TOPO vector) was cleaved with SspI and MluI. The puriﬁed
DNA was ligated into the SspI- and MluI-cleaved intermediate vector
to generate recombinant pI/5A-GFP-6 vector expressing Wt or
Table 2
List of primers used in these studies.
Mutation Orientation Restriction sitea Sequence
Δ193–261 Fwd SalI 5′-GCTCTAGCTAGCGTCGACATGGCCTCACAACTTCCTTACATCGAG-3′
Rev BamHI 5′-CGCGGATCCGCAGTATTGCTGCGCACACGACCCCGA-3′
Δ227-261 Fwd SalI 5′-GCTCTAGCTAGCGTCGACATGGCCTCACAACTTCCTTACATCGAG-3′
Rev BamHI 5′-CGCGGATCCGCTCAGGCACATAGTGCGTAGGGGA-3′
Δ227-250 Fwd QC 5′-CAGTGGATCAACGAGGACTGC-3′
Rev QC 5′-CTCAGGCACATAGTGCGTGGG-3′
Δ1-192 Fwd XhoI 5′-GCGGATCTCGAGACATGCGTCGGCACGTGGGCCCA-3′
Rev EcoRI 5′-GGGGCAGAATTCCGCATGGCGTGGAGCAGTCCTCGT-3′
D228A Fwd QC 5′-GCTGCTGCAGCACGTGTCACTCAG-3′
Rev QC 5′-GCTCTCAGGCACATAGTGCGT-3′
V233R Fwd QC 5′-CGTACTCAGATCCTCTCTAGTCTT-3′
Rev QC 5′-ACGTGCTGCAGCGTCGCTCTC-3′
L237E Fwd QC 5′-GAGTCTAGTCTTACCATCACTCAG-3′
Rev QC 5′-GATCTGAGTGACACGTGCTGC-3′
S239W Fwd QC 5′-TGGCTTACCATCACTCAGCTGCTG-3′
Rev QC 5′-AGAGAGGATCTGAGTGACACG-3′
T241A Fwd QC 5′-GCAATCACTCAGCTGCTGAAGAGG-3′
Rev QC 5′-AAGACTAGAGAGGATCTGAGT-3′
L245D Fwd QC 5′-GACCTGAAGAGGCTTCACCAGTGG-3′
Rev QC 5′-CTGAGTGATGGTAAGACTAGA-3′
H250E Fwd QC 5′-GAGCAGTGGATCAACGAGGACTGC-3′
Rev QC 5′-AAGCCTCTTCAGCAGCTGAGT-3′
NS4B (+)b Fwd SalI 5′-GCTCTAGCTAGCGTCGACATGGCCTCACACCTCCCTTACATCGAA-3′
NS4B (−)b Rev BamHI 5′-CGCGGATCCGGCATGGCGTGGAGCAGTCCTCGTT-3′
QC Refers to primers used for quikChange mutagenesis in pCR 2.1-TOPO. Mutations are denoted in bold.
a Restriction sites underlined.
b Refers to primers used to amplify NS4B point mutations in pCR 2.1-TOPO for cloning into pEGFP N2.
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replicons were conﬁrmed by DNA sequencing.
We also engineered a recombinant pIRES vector (Clontech)
containingNS5AGFP subgenomic replicon (pIR/I5AGFP)DNA sequence
to express Wt and mutant HCV polyproteins under the transcriptional
control of both CMV and T7 promoters. To this end, pI5AGFP-6
(Moradpour et al., 2004)] vector was digested with XbaI (5′ end) and
MluI (3′ end) and the resulting 5′ UTR-neo-NS3-NS4A-NS4B-NS5A
fragment was ligated into NheI- and MluI-cleaved pIRES vector. Next,
pI5AGFP-6 vector was digested with MluI and EcoRV and the resulting
NS5A-NS5B-3′ UTR fragment was ligated into MluI- and SmaI-cleaved
pIRES vector. Finally, the recombinant pIRES vector, with NS5A-NS5B-
3UTR, was digested with MluI and NotI, and the puriﬁed MluI-NS5A-
NS5B-3′UTR-NotI fragmentwas ligated into theMluI- andNotI-cleaved
pIRES vector, containing 5′ UTR-neo-NS3-NS4A-NS4B-NS5A fragment,
to generate pIR/I5AGFP vector.
Antibodies
Rabbit polyclonal antibody to HCV NS4B was obtained from
Covance (Denver, PA) whereas mouse monoclonal antibody to NS4B
was from Abcam (Cambridge, MA). Rabbit polyclonal antibodies to
HCV NS3, NS5A and NS5B were generous gifts from Craig Cameron's
laboratory (Penn State University, University Park). Rabbit polyclonal
antibody to GFP and Rab5 were obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA). Calnexin and GAPDH antibodies were from
Stressgen (Ann Arbor, MI) and Fitzgerald industries International, Inc.
(Concord, MA), respectively. Horseradish peroxidase-conjugated
secondary antibodies were obtained from Vector Laboratories
(Burlingame, CA). Alexa ﬂuor-conjugated secondary antibodies were
obtained from Invitrogen (Carlsbad, CA).
DNA transfection
For each experiment, parental cells (Huh7.5) or NS5AGP sub-
genomic replicon-expressing cells were trypsinized and grown
overnight in 10 cm dishes or 6-well plates to obtain 70–80% conﬂuent
monolayer cells. Prior to transfection, the cells were washed withphosphate-buffered saline (PBS) and fed with 10 ml of fresh complete
medium (for 10 cmdishes) or 2ml of completemediumperwell for 6-
well plates. Cells were transfected according to the TransIT-LT1
protocol from Mirus(Madison, WI). The DNA mixture was added to
each dish and incubated at 37 °C for 24 or 48 h. With this procedure,
DNA transfection efﬁciency was usually 70–90%.
Membrane ﬂoatation assay
For membrane ﬂoatation assay, 2–3 ×100 mm dishes (7×105
cells/dish) of parental cells (Huh7.5) were grown overnight and
transfected as described above. Transfected cells were resuspended in
homogenization buffer (150mMNaCl, 50mMTris pH7.4, 2mMEDTA)
containing protease inhibitors (1 mM PMSF and 1 tablet of Complete
Mini; Roche, Nutley, NJ). The cells were then lysed with 6–8 passages
in a ball-bearing homogenizer to ensure approximately 90% lysis. Cell
lysates were spun at 2500 ×g/10 min at 4 °C to pellet cellular debris
and nuclei. A discontinuous iodixanol gradient (5%, 25% and 30%)
(Elazar et al., 2004) was layered on the top of the homogenate and the
sampleswere spun at 120,000 ×g for 4 h 25min at 4 °C in a Ti80 Rotor.
A total of 8 fractions (867 μl each) were collected from top to bottom.
Each fraction was precipitated as described above, separated on 10%
SDS-PAGE and processed for western blotting as described above.
Typically, membrane-bound proteins were associated with fractions 1
to 4 whereas soluble proteins were prominent in fractions 5 to 8.
Metabolic labeling and immunoprecipitation
Huh7.5 cells were seeded at 1.5×105 cells/10 cm dish approxi-
mately 24 h prior to transfection. Before transfection, the cells were
washed once in PBS and fed with fresh DMEM/10%FBS. The cells were
co-transfected with 10 μg of DNA encoding Wt or mutant NS5A-GFP
replicon in pIRES vector (pIRES-I/5A-GFP) and 5 μg of plasmid DNA
encoding T7 polymerase (pCAGGS-T7 kindly provided by Biao He, The
Pennsylvania State University). Parental cells, co-transfected with
pIRES and T7 polymerase-encoding vector, were used as negative
controls. DNA transfection with TransIT-LT1 reagent was done as
described above.
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twice with PBS. Each sample was then resuspended in 1 ml of DMEM
without cysteine and methionine (Invitrogen) and incubated at 37 °C
with gentle rotation for 1 h. After starvation, the cells were labeled
with 200 μl of 500 μCi/ml Express 35S protein labeling mix (Perkin-
Elmer) for 10–15 min. The cells were evenly split into aliquots, and
some were lysed immediately in 1 ml of ice-cold RIPA buffer
[150 mM NaCl, 50 mM Tris, pH 8.0, 1 mM EDTA, 1% NP-40, 0.1%
SDS, 1 mM phenylmethylsulfonyl ﬂuoride and complete protease
inhibitor cocktail (Roche)]. Alternatively, the remaining label was
removed after brief centrifugation (500 ×g/1 min), replaced with
complete DMEM containing 10 mM cysteine/methionine (pH 7.4),
followed by a chase and lysis with 1 ml of ice-cold RIPA buffer. Cell
lysates were precleared by incubation for 1 h at 4 °C with Protein A/G
Plus agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA). The
supernatants were then incubated with HCV-speciﬁc antibodies at a
dilution of 1:500 (anti-NS3, NS5A, or NS5B) or 1:250 (anti-NS4B) for
3–12 h at 4°C, mixed with protein A/G Plus agarose and incubated for
2 h at 4 °C. Protein A/G agarose Plus-bound complexes were collected
by centrifugation at 500 ×g/5 min, washed once with RIPA buffer,
once with RIPA buffer/500 mM NaCl and once more with RIPA buffer.
To examine the immuno-precipitates by sodium dodecyl sulfate-
polyacrylamide gels (SDS-PAGE), the samples were resuspended in
30 μl of loading buffer (Laemmli, 1970), heated at 95 °C/5-10 min
and centrifuged at 14,000 ×g/2 min. The supernatants were
separated on 10% SDS-PAGE, ﬁxed in 20% methanol/7% acetic acid
for 10 min at room temperature, and dried for 1 h at 80 °C. Labeled
proteins were visualized and quantitated on a PhosphorImager
(Typhoon 8600, Amersham Pharmacia Biotechnology Inc./Molecular
Dynamics, Piscataway, NJ).
In vitro transcription, electroporation and generation of
G418-resistant cells
Plasmid DNA containing subgenomic NS5AGFP replicon (pI/5A-
GFP-6) (Moradpour et al., 2004) constructs were linearized with ScaI
and puriﬁed using the QIAquick PCR puriﬁcation kit (Qiagen,
Valencia, CA). RNA was synthesized using the T7 RiboMAX Express
Large Scale RNA Production Systems Kit (Promega, Madison, WI)
according to the manufacturer's instructions. The RNA was then
isolated using the RNeasy miniprep kit (QIAGEN, Valencia, CA). Prior
to electroporation, subconﬂuent Huh7.5 cells were trypsinized and
resuspended in complete DMEM. The cells were then washed three
times and resuspended at a concentration of 6.25×106 cells/ml in
OptiMEM. For each electroporation, 0.4 ml of the cell suspension
(2.5×106 cells) was mixed with 5 μg of HCV replicon RNA and
electroporated in a 0.2-mm gap cuvette in a Bio-Rad Gene Pulser (1
pulse, 0.13 kV). The cell suspension was recovered in complete
DMEM for 10 min on ice prior to plating in a 10 cm dish. Resus-
pended cells (1×104, 1×105, 2.5×105 and 5×105) were seeded in
10 cm dishes together with cells electroporated with polymerase-
deﬁcient replicon RNA to obtain 5×105 cells per dish. After 24 h
incubation, the medium was changed and replaced with complete
medium supplemented with 0.5 mg/ml G418. The medium was
changed every three to four days for three weeks. G418-resistant
colonies were ﬁxed with 4% formaldehyde/PBS and stained with
0.1% crystal violet in 70% ethanol. G418-resistant clones were
counted and used to calculate the colony forming efﬁciency per
microgram of input RNA (CFU/μg).
Fluorescence microscopy
Huh7.5 cells were seeded onto coverslips and transfected in 10 cm
dishes or 6-well plates as described above. At 48 h post-transfection,
the coverslips were washed with PBS and ﬁxed for 10 min in 4%
formaldehyde/PBS. The cells were then permeabilized for 5 min atroom temperature in 0.05% Triton-X 100/PBS, followed by staining
with NS3 rabbit polyclonal antibody (or NS4B staining with a mouse
monoclonal antibody) and Alexa ﬂuor 594-conjugated secondary
antibody. After three washes in PBS, the cells were stained with DAPI/
PBS for 10 min at room temperature, followed by three more washes
in PBS. The cells were mounted on glass slides in Vectashield (Vector
Laboratories, Inc., Burlingame, CA) and the coverslips sealed with nail
polish. The samples were then examined by ﬂuorescence microscopy
(Zeiss Axiovert 200 M) with a 63× lens. Digital images were taken
with an AxiocamMRm CCD camera. An image stack was deconvolved
using the iterative mode of the Axiovision software to exclude out-of-
focus information. Images were saved as TIFF ﬁles, imported and
processed in Adobe Photoshop.
Immunoblot analysis
Transfected cells or replicon cells were lysed in RIPA buffer
(150 mM NaCl, 50 mM Tris, pH 8.0, 1 mM EDTA, 1% NP-40, 0.1% SDS,
1 mM phenylmethylsulfonyl ﬂuoride, and 2 μg/ml leupeptin) and
protein concentrations determined by Bio-Rad protein assay. Fifty to
100 μg of total protein were typically resuspended in 4× SDS loading
buffer (240 mM Tris pH 6.8, 4% SDS, 40% glycerol, 4% β-mercap-
toethanol, 0.01% bromophenol blue) and boiled for 5 min at 95 °C. The
proteins were separated on 10% sodium dodecyl sulfate-polyacryl-
amide gel (SDS-PAGE) followed by transfer onto an Immobilon-P
membrane (PVDF; Millipore, Billerica, MA). Antibody-bound proteins
were detected by enhanced chemiluminescence detection method
(ECL, Pierce, Rockford, Il).
Electron microscopy
For ultrastructural analysis, cells expressing GFP, NS4BGFP or the
various mutant constructs were trypsinized, resuspended in complete
DMEMand processed as follows. Brieﬂy, the cells were resuspended in
2% glutaraldehyde/0.1 M sodium cacodylate buffer and incubated on
ice for 30 min. After a brief spin, fresh 2% glutaraldehde/0.1 M sodium
cacodylate was added to the pellet and the pellet was incubated
overnight at 4 °C. The cell pellet was rinsed with 0.1 M sodium
cacodylate prior to postﬁxation with 1% osmium tetroxide/0.1 M
cacodylate for 1–2 h at 4 °C. After rinsing and en bloc staining in
aqueous uranyl acetate, samples were dehydrated with graded
ethanol concentrations, inﬁltrated with eponate resin and embedded
overnight in eponate at 65 °C. Ultrathin sections were cut on Leica
Ultracut UCT microtome (Wetzlar, Germany), collected on copper
grids and stained with 1% uranyl acetate–1% lead citrate. The sections
were imaged at 80 kV in a JEOL JEM 1200 EXII (Peabody, MA) electron
microscope.
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